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Wijeyaratne S.M., Collins M.A., Barth J.H., Gough M.J. Eur J Vasc Endo-
vasc Surg 2009;38:262-266.
Introduction: Previous studies indicate that local (LA) rather than
general anaesthesia (GA) for carotid endarterectomy (CEA) is associated
with reflex hypertension and preservation of cerebral cytochrome oxidase
after carotid clamping. The hypothesis that LA offers protection against
ischaemic cerebral injury has been investigated by measuring ipsilateral
jugular venous neurone specific enolase (NSE: neuronal glycolytic enzyme)
and S-100B (glial cell protein) during and after CEA.
Methods: 27 patients with symptomatic carotid artery disease (70–
99% stenosis) underwent CEA, 14 under LA and 13 under GA. Jugular
venous blood samples were assayed for NSE and S-100B before carotid
clamping and at 5 min before and 5 min, 2, 4, 6, 8, 12 and 24 h after clamp
release.
Results: No neurological complications occurred. S-100B levels
were low and did not increase from baseline in either group. Pre-clamp
NSE levels were similar in both groups (LA: 17.6 (15.2–20.7) g/l, GA:
21.5 (11.3–26.2) g/l; p  0.37) but increased significantly 2 h after
clamp release in GA patients (LA: 25.5 (16.6–27.8) g/l, GA: 48.2
(31.4–61.3) g/l, p  0.05) with a significant rise from baseline in GA
patients (p  0.04).
Conclusions:CEA performed under GA is associated with greater rises
in jugular venous NSE, and hence cerebral injury, than CEA performed
under LA.
The EndovascularManagement of Penetrating Carotid Artery Injuries:
Long-term Follow-up
du Toit D.F., Coolen D., Lambrechts A., de V. Odendaal J., Warren B.L.
Eur J Vasc Endovasc Surg 2009;38:267-272.
Objectives: To review a single-centre experience with stent-graft treat-
ment of penetrating carotid artery injuries and long-term follow-up.
Methods: All stable patients with carotid artery injuries presenting
between August 1998 and February 2009 were considered for endo-
vascular treatment. Patients were selected based on clinical and radio-
logical criteria and data were prospectively collected. Follow-up was
conducted clinically, angiographically and by telephonic contact. End-
points were stroke, death and any other stent-graft-related complica-
tions.
Results: A total of 128 patients were treated, of whom only 19 were
selected for endovascular management. The recorded technical success rate
was 100%, with one early stroke and one non-stent-graft-related procedural
death. A further four patients were lost to follow-up. The remaining 14
patients had a mean follow-up of nearly 4 years. No stent-graft-related late
deaths, strokes or other complications were reported, although one instance
of late stent-graft occlusion was documented.
Conclusion: Endovascular management of penetrating carotid artery
injuries is safe and the long-term outcomes justify a more liberal application
of this technique in selected patients.
The Importance of Anatomical Suitability and Fitness for the Outcome
of Endovascular Repair of Ruptured Abdominal Aortic Aneurysm
Richards T., Goode S.D., Hinchliffe R., Altaf N., MacSweeney S., Braith-
waite B. Eur J Vasc Endovasc Surg 2009;38:285-290.
Introduction: Endovascular repair of aortic aneurysm (EVAR) has a
lower mortality than open repair. The aim of this study was to assess
mortality fromEVAR for emergency AAA repair and the impact of fitness for
operation and adverse anatomy.
Methods: One-hundred and forty two patients who had EVAR for a
ruptured AAA (80, REVAR) or a symptomatic AAA (62, SEVAR) between
1994 and 2007 in a single specialist endovascular centre were reviewed.
Fitness for surgery was assessed by Hardman’s index (age  76, loss of
consciousness, Hb  9.0, Cr  190, ischaemic ECG). CT scans were re-
viewed, compared with operative images and operation notes for adverse
anatomy. Details of perioperative complications, and outcome were re-
corded.Results:Overall mortality at 24-h, 30-days and one year were, respec-
tively: 17%, 36%, 50% for REVAR and 5%, 8%, 23% for SEVAR. Overalladverse anatomy increased 30-day mortality. Hardman’s index of three or
more increased mortality HR  2.59 (1.24–5.41), p  0.01. On Cox re-
gression Univariate analysis increasing Hardman’s index score and adverse
anatomy increased the overall mortality over time. In multivariate Cox
regression analysis (controlled for the Hardman’s index) adverse anatomy
was associated with significant increase in graft related mortality.
Conclusion: The use of EVAR is feasible in patients who present with
a ruptured or acutely symptomatic AAA. Care must be taken not to extend
anatomical or clinical guidelines.
AComparison of theMid-termResults Following the use of Bifurcated
and Aorto-uni-iliac Devices in the Treatment of Abdominal Aortic
Aneurysms
Jean-Baptiste E., Batt M., Azzaoui R., Koussa M., Hassen-Khodja R.,
Haulon S. Eur J Vasc Endovasc Surg 2009;38:298-304.
Purpose: To compare the mid-term results following the use of bifur-
cated (ABIS) and aorto-uniiliac (AUIS) endovascular devices in the treat-
ment of abdominal aortic aneurysms (AAA) in a population of patients
deemed to be at high risk for open surgery.
Material and methods: Over a 4 year period (January 2003 to
December 2007), 447 underwent elective endovascular aneurysm repair
(EVAR) using ZENITH® stent-grafts. Group I comprised patients treated
using the AUIS (n  124), and group II those receiving ABIS (n  323).
Outcomemeasures included the assisted technical success rate, perioperative
mortality, major complications, freedom from reintervention, and primary
and secondary patencies. Factors associated with mid-term clinical failures
were determined using univariate and multivariate analyses.
Results:The assisted primary technical success rate was 94% and 99% in
groups I and II respectively (p  .002). Major perioperative complications
occurred in 13 group I patients (10%) vs. 12 group II patients (4%)
(p  .005). The 30-day mortality rate was 3.2% vs.1.5% (p  0.2). TASC C
and D iliac lesions significantly increased the risk of major perioperative
complications (35% vs. 3%; OR  14.94; 95% CI: 5.75 to 38.78;
p  .0001). During the follow-up period (median 24 months), secondary
procedures were required in 11% and 5% of group I and group II patients
respectively (p  .01). Freedom from reintervention at 12, 24 and 36
months was 98%, 90%, and 85% in group I vs. 96%, 92%, and 92% in group
II (P  0.005). The primary and secondary patency rates at 3 years were 92%
vs. 98% (p  .003) and 97% vs. 99% (p  .04) for groups I and II respec-
tively. In group I, the Crossover Femoro-Femoral Bypass (CFFB) was
responsible for 3 major complications (2.4%) which occurred at 7, 12 and 57
months of follow-up. However, the use of AUIS with CFFB did not
independently increase the risk of major complications during follow-up
(HR  0.108; 95%CI: 0.007 to 1.637; p  .11, Cox proportionmodel). In
both univariate and multivariate analysis, concomitant iliac arterial occlusive
disease (IAOD) was the only significant predictor of clinical failure in study
population as a whole (OR  3.996; 95% CI: 1.996 to 7.921; p  .0001).
Conclusion: This study demonstrates that ABIS is associated with
better results than AUIS in the management of patients with AAA. Iliac
artery occlusive disease was more frequently diagnosed in the AUIS group
and this was significantly associated with a higher risk of complications, while
the crossover graft itself was not. Nevertheless, the outcomes for both
groups are encouraging in this high risk population.
Prevalence of Symptomatic and Asymptomatic Peripheral Arterial Dis-
ease and the Value of the Ankle-brachial Index to Stratify Cardiovas-
cular Risk
Ramos R., Quesada M., Solanas P., Subirana I., Sala J., Vila J., Masiá R.,
Cerezo C., Elosua R., Grau M., Cordón F., Juvinyà D., Fitó M., Isabel
Covas M., Clarà A., Ángel Muñoz M., Marrugat J., on behalf of the
REGICOR Investigators. Eur J Vasc Endovasc Surg 2009;38:305-311.
Objectives: To determine the prevalence of ankle-brachial index
(ABI)  0.9 and symptomatic peripheral arterial disease (PAD), association
with cardiovascular risk factors (CVRF), and impact of adding ABI measure-
ment to coronary heart disease (CHD) risk screening.
Design: Population-based cross-sectional survey of 6262 participants
aged 35–79 in Girona, Spain.Methods: Standardized measurements (CVRF, ABI, 10-year CHD
risk) and history of intermittent claudication (IC), CHD, and stroke were
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risk (10%).
Results: ABI  0.9 prevalence was 4.5%. Only 0.62% presented low
ABI and IC. Age, current smoker, cardiovascular disease, and uncontrolled
hypertension independently associated with ABI  0.9 in both sexes; ICwas
also associated in men and diabetes in women. Among participants 35–74
free of cardiovascular disease, 6.1% showed moderate-to-high 10-year CHD
risk; adding ABI measurement yielded 8.7%. Conversely, the risk function
identified 16.8% of these participants as having 10-year CHD risk  10%. In
participants 75–79 free of cardiovascular disease, the prevalence of
ABI  0.9 (i.e., CHD risk  10%) was 11.9%.
Conclusions: ABI  0.9 is relatively frequent in those 35–79, partic-
ularly over 74. However, IC and CHD risk  10% indicators are often
missing. Adding ABI measurement to CHD-risk screening better identifies
moderate-to-high cardiovascular risk patients.
Subintimal Angioplasty: Meta-analytical Evidence of Clinical Utility
Bown M.J., Bolia A., Sutton A.J. Eur J Vasc Endovasc Surg 2009;38:323-
337.
Objectives: The aim of this study was to determine accurate estimates
of the success rate of subintimal angioplasty in terms of ability to recanalise
occluded vessels, patency over time and limb salvage rates.
Design: A meta-analysis of published literature.
Materials: All studies reporting unique patient data published in
English language between 1989 and 2008.
Methods: Separate meta-analyses were performed for immediate tech-
nical success, 12-month patency rates and 12-month limb salvage rates.
Longer-term outcomes were analyzed in separate meta-analyses. Meta-
regression was applied to determine whether any of these outcomes had
improved over time.
Results: Pooled estimates for technical success, primary patency at 12
months and limb salvage at 12 months were 85.7% (95% confidence interval:
83.3%–87.7%, 2810 limbs), 55.8% (95% confidence interval: 47.9%–63.4%,
1342 limbs), and 89.3% (95% confidence interval: 85.5%–92.2%, 2810 limbs),
respectively. Regression analysis demonstrated no significant change in out-
comes over time. There was some evidence of publication bias, however, after
adjusting for this there was little change in the pooled outcome estimates.
Conclusions: This study demonstrates that the outcomes for subinti-
mal angioplasty are good and that this method should be considered as an
alternative to surgical bypass.
A 15-Year Experience with Combined Vascular Reconstruction and
Free Flap Transfer for Limb-Salvage
RandonC., Jacobs B., De Ryck F., Van Landuyt K., Vermassen F. Eur J Vasc
Endovasc Surg 2009;38:338-345.
Objectives: To evaluate the results and complications of combined
simultaneous arterial re-vascularisation and free flap transfer in patients with
critical limb ischaemia and large soft-tissue defects that would otherwise
have required major amputation.Design: Retrospective analysis of all combined procedures performed
between 1993 and 2007 with regard to complications and outcome.Materials and methods: Seventy-eight procedures were performed in
76 patients with a mean age of 60 years (range: 18–80 years). The majority
had diabetes (70.5%). Follow-up was obtained from hospital charts and
telephone contacts with patients or GPs.
Results: The limb-salvage rate was 93% after 1 year, 80% after 3 years
and 71% after 5 years. Perioperative complications occurred in 50% of the
patients; six out of 78 (7.7%) arterial reconstructions and 13 out of 78
(16.7%) flaps had to be revised during the early postoperative period.
However, most flaps could be saved by a secondary procedure resulting in an
early failure (amputation) rate of 6%.
In-hospital mortality was 3.8%. End-stage renal disease was the only
factor predicting limb loss. In total, 65% of the patients survived and were
able to walk on their reconstructed limb at 1-year follow-up. Combined
survival and limb-salvage rates were 85%, 66% and 51% after 1, 3 and 5 years.
Conclusions: Combined arterial re-vascularisation and free flap trans-
fer can be performed safely with acceptable morbidity and mortality and
should be considered for every mobile patient with large soft-tissue deficit
(10 cm2) without end-stage renal disease prior to major amputation.
Lower-extremity Arteriovenous Access for Haemodialysis: A System-
atic Review
Antoniou G.A., Lazarides M.K., Georgiadis G.S., Sfyroeras G.S., Nikolo-
poulos E.S., Giannoukas A.D. Eur J Vasc Endovasc Surg 2009;38:365-372.
Background: The lower extremity is increasingly used as an access site in
end-stage renal disease patients. However, reports present conflicting results,
creating confusion regarding the feasibility and outcomes. Our objective is to
review the available literature and analyse the patency rates and complications of
various types of lower-extremity arteriovenous access.
Methods: An Internet-based literature search was performed using
MEDLINE to identify all published reports on lower-extremity vascular
access. The analysis involved studies comprising at least 10 arteriovenous
accesses with both inflow and outflow vessels in the lower extremity, and
reporting on patency rates and access-related complications. The weighted
mean patency rates were calculated, and the chi-square (2) test was used to
evaluate the differences in the complication rates in the subgroups of patients
identified.
Results: Three main types of lower-extremity vascular access were
identified: the upper thigh prosthetic, the mid-thigh prosthetic and the
femoral vein transposition arteriovenous access. There are limited data on
saphenous vein loop grafts, which report poor results. The weighted mean
primary patency rates at 12 months were 48%, 43% and 83%, respectively.
The weighted mean secondary patency rates at 12 months were 69%, 67%
and 93%, respectively. Access loss as a result of infection was more common
in upper thigh and mid-thigh grafts than femoral vein transposition arterio-
venous access (18.40%, 18.33% vs. 1.61%; P  0.05). Ischaemic complica-
tions rates were higher in autologous than prosthetic arteriovenous access
(20.97% vs. 7.18%, P  0.05).
Conclusions: Lower-extremity vascular access has acceptable results in
terms of patency, with femoral vein transposition having better patency rates
than femoral grafts. Autologous access is associated with less infective
complications, however, at the expense of increased ischaemic complications
rates. Further research with randomised trials is required to assess the
outcomes of lower-extremity vascular access.
